Mélissa Thomas

876 total citations
26 papers, 430 citations indexed

About

Mélissa Thomas is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Mélissa Thomas has authored 26 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Surgery and 6 papers in Oncology. Recurrent topics in Mélissa Thomas's work include Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Esophageal and GI Pathology (5 papers). Mélissa Thomas is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Gastric Cancer Management and Outcomes (9 papers) and Esophageal and GI Pathology (5 papers). Mélissa Thomas collaborates with scholars based in Belgium, United States and Australia. Mélissa Thomas's co-authors include Karin Haustermans, Gilles Defraene, Harry Keyserling, DEBORAH A. HOGERMAN, Crystal L. Johnson, Dace V. Madore, Kathryn M. Edwards, M. C. Steinhoff, Edmond Sterpin and John A. Lee and has published in prestigious journals such as Nucleic Acids Research, Gastroenterology and PLoS ONE.

In The Last Decade

Mélissa Thomas

24 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélissa Thomas Belgium 14 154 113 93 86 78 26 430
Mark Arends United Kingdom 5 75 0.5× 161 1.4× 273 2.9× 56 0.7× 177 2.3× 6 519
Subhashini John India 12 73 0.5× 105 0.9× 151 1.6× 49 0.6× 59 0.8× 31 449
M.A. Ritter United States 10 341 2.2× 41 0.4× 14 0.2× 19 0.2× 70 0.9× 28 447
Lijuan Wan China 13 71 0.5× 85 0.8× 108 1.2× 116 1.3× 216 2.8× 44 509
William P. Irvin United States 17 82 0.5× 227 2.0× 225 2.4× 158 1.8× 49 0.6× 26 821
Davide Berlato United Kingdom 14 516 3.4× 78 0.7× 26 0.3× 56 0.7× 16 0.2× 31 623
I. Aref United States 12 165 1.1× 63 0.6× 64 0.7× 159 1.8× 120 1.5× 28 602
R. Mendes United Kingdom 13 174 1.1× 39 0.3× 40 0.4× 72 0.8× 205 2.6× 26 542
M Vanderhoek United States 6 133 0.9× 19 0.2× 18 0.2× 49 0.6× 199 2.6× 12 344
Nicholas Detorie United States 8 114 0.7× 40 0.4× 56 0.6× 207 2.4× 88 1.1× 17 497

Countries citing papers authored by Mélissa Thomas

Since Specialization
Citations

This map shows the geographic impact of Mélissa Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélissa Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélissa Thomas more than expected).

Fields of papers citing papers by Mélissa Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélissa Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélissa Thomas. The network helps show where Mélissa Thomas may publish in the future.

Co-authorship network of co-authors of Mélissa Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Mélissa Thomas. A scholar is included among the top collaborators of Mélissa Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélissa Thomas. Mélissa Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandamme, Timon, Geert Roeyen, Dries Reynders, et al.. (2025). Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO).. BMC Cancer. 25(1). 1671–1671.
2.
O’Sullivan, Julia, Charu Kothari, Marie‐Christine Caron, et al.. (2023). ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance. Nucleic Acids Research. 51(20). 11056–11079. 6 indexed citations
3.
4.
Thomas, Mélissa, Junan Li, Avinash K. Persaud, et al.. (2023). <i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplant. Haematologica. 108(8). 2155–2166. 13 indexed citations
5.
Lee, Mark, David J. Willis, Shahida Ahmed, et al.. (2023). The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG). International Journal of Radiation Oncology*Biology*Physics. 117(5). 1096–1106. 5 indexed citations
6.
Montero, Ana María Barragán, Mélissa Thomas, Gilles Defraene, et al.. (2022). Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer. Radiotherapy and Oncology. 176. 101–107. 18 indexed citations
7.
Montero, Ana María Barragán, Mélissa Thomas, Gilles Defraene, et al.. (2021). Deep learning dose prediction for IMRT of esophageal cancer: The effect of data quality and quantity on model performance. Physica Medica. 83. 52–63. 46 indexed citations
8.
Thomas, Mélissa, Hanna Rahbek Mortensen, Lone Hoffmann, et al.. (2020). Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer. Radiotherapy and Oncology. 156. 102–112. 16 indexed citations
9.
Thomas, Mélissa, Gilles Defraene, Mario Levis, et al.. (2020). A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer. Physics and Imaging in Radiation Oncology. 16. 50–53. 3 indexed citations
10.
Thomas, Mélissa, Robin De Roover, Van der Merwe, et al.. (2020). The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment. Clinical and Translational Radiation Oncology. 26. 8–14. 3 indexed citations
11.
Thomas, Mélissa, Gilles Defraene, Maarten Lambrecht, et al.. (2019). NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer. Radiotherapy and Oncology. 141. 33–40. 34 indexed citations
12.
Mååg, Jesper L.V., Oliver M. Fisher, Angelique Levert‐Mignon, et al.. (2017). Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing. Molecular Cancer Research. 15(11). 1558–1569. 32 indexed citations
13.
Cohen, Adam L., Randy L. Jensen, Dennis C. Shrieve, et al.. (2017). ACTR-84. D-TERMINED: A PHASE 1 TRIAL IN NEWLY DIAGNOSED HIGH GRADE GLIOMA WITH TEMOZOLOMIDE, RADIATION, AND MINOCYCLINE FOLLOWED BY ADJUVANT MINOCYCLINE/TEMOZOLOMIDE. Neuro-Oncology. 19(suppl_6). vi19–vi19. 1 indexed citations
14.
Levert‐Mignon, Angelique, Michael J. Bourke, Sarah J. Lord, et al.. (2016). Changes in gene expression of neo‐squamous mucosa after endoscopic treatment for dysplastic Barrett’s esophagus and intramucosal adenocarcinoma. United European Gastroenterology Journal. 5(1). 13–20. 1 indexed citations
15.
Fisher, Oliver M., Angelique Levert‐Mignon, Natalia K. Botelho, et al.. (2016). CD151 Gene and Protein Expression Provides Independent Prognostic Information for Patients with Adenocarcinoma of the Esophagus and Gastroesophageal Junction Treated by Esophagectomy. Annals of Surgical Oncology. 23(S5). 746–754. 8 indexed citations
16.
Fisher, Oliver M., Angelique Levert‐Mignon, Sarah J. Lord, et al.. (2015). MIC-1/GDF15 in Barrett’s oesophagus and oesophageal adenocarcinoma. British Journal of Cancer. 112(8). 1384–1391. 15 indexed citations
17.
Fisher, Oliver M., Angelique Levert‐Mignon, Sarah J. Lord, et al.. (2014). High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett’s Esophagus and Adenocarcinoma. Annals of Surgical Oncology. 22(7). 2431–2438. 13 indexed citations
18.
Fisher, Oliver M., Angelique Levert‐Mignon, Sarah J. Lord, et al.. (2014). Mo2048 Cathepsin E Is a Novel Highly Overexpressed Biomarker in Barrett's Esophagus & Esophageal Adenocarcinoma. Gastroenterology. 146(5). S–1075. 1 indexed citations
19.
LaPointe, Lawrence C., Susanne K. Pedersen, Robert Dunne, et al.. (2012). Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing. PLoS ONE. 7(1). e29059–e29059. 35 indexed citations
20.
Steinhoff, M. C., Kathryn M. Edwards, Harry Keyserling, et al.. (1994). A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children. The Pediatric Infectious Disease Journal. 13(5). 368–372. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Arends Breakdown of academic impact, for papers by Subhashini John Breakdown of academic impact, for papers by M.A. Ritter Breakdown of academic impact, for papers by Lijuan Wan Breakdown of academic impact, for papers by William P. Irvin Breakdown of academic impact, for papers by Davide Berlato Breakdown of academic impact, for papers by I. Aref Breakdown of academic impact, for papers by R. Mendes Breakdown of academic impact, for papers by M Vanderhoek Breakdown of academic impact, for papers by Nicholas Detorie
Rankless by CCL
2026